Prostate-specific membrane antigen PET-MRI validation of MR textural analysis for detection of transition zone prostate cancer? – Feedback (FDBK)
Feedback (FDBK) – Prostate-specific membrane antigen PET/MRI validation of MR textural analysis for detection of transition zone prostate cancer? Source Bates A, et al. Eur Radiol. 2017. OBJECTIVES: To validate MR textural analysis (MRTA) for detection of transition zone (TZ) prostate cancer through […]
Feedback PLC director Dr Balaji Ganeshan discusses the latest TexRAD developments
Feedback PLC director Dr Balaji Ganeshan joins Justin Waite on the ADVFN podcast to discuss the latest developments with TexRAD in regard to joint ventures for prognosis and treatment for Lung Cancer, Kidney Stones and Prostate Cancer. He also explains the background of the company, how doctors use and access the software. The interview is […]
Strategic alliance between Quibim and Feedback Plc to improve prostate biopsy
From the Spanish medical website Tu hospital investiga para ti The Spin-Off of the IIS La Fe, Quibim has established a strategic alliance with UK company Feedback Plc to develop Prostate Checker, a tool that will improve the diagnosis of prostate cancer. Feedback Plc acquired last year TexRAD company dedicated to the analysis of tumor from medical […]
Malcolm Stacey of ShareProphets – Feedback and the Big Spanish Connection
Hello Share Thrashers. It’s not my custom to return to promising shares I’ve brought to your attention in the recent past. I normally wait at least six months or so – with only a few exceptions. But the story is growing fast for one bio science company that I’ve featured quite recently – Feedback (FDBK). […]
Advanced Oncotherapy – Men should have open dialogue about screening, treatment for prostate cancer
Men should have open dialogue about screening, treatment for prostate cancer By Michaela Morris in Health, Lifestyle, Daily Journal Dick Guyton is glad he made the decision to continue with prostate cancer screening. After being diagnosed with early stage disease in May 2013, he took his time and gathered all the options for treatment […]